Cancer therapy and synthetic biology are converging around a shared problem that has long frustrated oncologists and ...

Randomness inside cells can decide whether a cancer returns after chemotherapy or whether an infection survives antibiotics.

A study led by researchers at Moffitt Cancer Center found that normal cells surrounding a tumor, known as cancer-associated ...

Long before a liver tumor appears, a high-fat diet can push liver cells into a risky survival mode. That is the central ...

A study shares new insights into how two of the most common types of chimeric antigen receptor (CAR) T cells kill cancer. Investigators examined how molecular dynamics at the immune synapse -- where ...

Immune cells work to fight infection and other diseases. Different subsets work together to elicit a healthy immune response; ...

Researchers have created tiny metal-based particles that push cancer cells over the edge while leaving healthy cells mostly unharmed. The particles work by increasing internal stress in cancer cells ...

CAR-T therapy is a major advance in cancer care, but high costs and centralized global manufacturing limit access.

Tumours have developed many strategies and tricks to gain advantages in the body. Led by cell biology professor Sabine Werner, researchers at ETH Zurich have now discovered another surprising trick ...

Amgen is getting down with Disco Pharmaceuticals, commissioning the German biotech to work on cancer therapies focused on a ...

Cancer cells can brainwash their neighbors. Like the CIA deploying secret agents to turn an enemy, tumors use a similar strategy to manipulate nearby cells. The tumors’ agents are mitochondria, the ...

While our cells are performing some important, basic functions, they can generate compounds known as reactive oxygen species ...